Risk of second primary cancer among esophageal cancer patients: A pooled analysis of 13 cancer registries

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1543-1549

  Chuang, Shu Chun ^a,b   Hashibe, Mia ^a   Scelo, Ghislaine ^a   Brewster, David H ^c   Pukkala, Eero ^d   Friis, Soren ^e   Tracey, Elizabeth ^f   Weiderpass, Elisabete ^g,h,i   Hemminki, Kari ^h,j   Tamaro, Sharon ^k   Chia, Kee Seng ^l,m   Pompe Kirn, Vera ⁿ   Kliewer, Erich V ^o   Tonita, Jon M ^p   Martos, Carmen ^q   Jonasson, Jon G ^r   Dresler, Carolyn M ^a   Boffetta, Paolo ^a   Brennan, Paul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INFORMATION SERVICES DIVISION   (United Kingdom)

^d FINNISH CANCER REGISTRY   (Finland)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f New South Wales Cancer Registry   (Australia)

^g CANCER REGISTRY OF NORWAY   (Norway)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ FOLKHÄLSAN RESEARCH CENTER   (Finland)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k BRITISH COLUMBIA CANCER AGENCY   (Canada)

^l Centre for Molecular Epidemiology   (Singapore)

^m Singapore Cancer Registry ^*  (Singapore)

ⁿ INSTITUTE OF ONCOLOGY   (Slovenia)

^o UNIVERSITY OF MANITOBA   (Canada)

^p SASKATCHEWAN CANCER AGENCY   (Canada)

^q Cancer Registry of Zaragoza   (Spain)

^r UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BLADDER CANCER; BREAST CANCER; CANADA; CANCER REGISTRY; CANCER RISK; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; EUROPE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NONHODGKIN LYMPHOMA; PHARYNX CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; RISK FACTOR; SECOND CANCER; SINGAPORE; STANDARDIZATION; STOMACH CANCER; TESTIS CANCER; THYROID CANCER;

AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RISK; RISK FACTORS; SURVIVAL RATE;

EID: 53349119032     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2876     Document Type: Article

References (34)

1. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov/) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2005 Sub (1973-2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. 2006.
2. Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003;14 Suppl 5:v61-118.
3. Layke JC, Lopez PP. Esophageal cancer: a review and update. Am Fam Physician 2006;73:2187-94.
4. Cheng KK, Day NE. Nutrition and esophageal cancer. Cancer Causes Control 1996;7:33-40.
5. Chainani-Wu N. Diet and oral, pharyngeal, and esophageal cancer. Nutr Cancer 2002;44:104-26.
6. Jakszyn P, Gonzalez CA. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 2006;12:4296-303.
7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
8. Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004;91:868-72.
9. Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002;99:860-8.
10. Forman D. Review article: oesophago-gastric adenocarcinoma - an epidemiological perspective. Aliment Pharmacol Ther 2004;20 Suppl 5:55-60.
11. Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 2007;13:1585-94.
12. Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005;3:1-10.
13. Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998;65:1529-34.
14. Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 2000;13:226-30.
15. Boice JD, Jr., Storm HH, Curtis RE, et al. Introduction to the study of multiple primary cancers. Multiple primary cancers in Connecticut and Denmark NCI-Bethesda: NIH Publication; 1985. p. 3-9.
16. Veli EM, Schatzkin A. Common environmental risk factors. In: Neugut AI, Meadows AT, Robinson E, editors. Multiple primary cancers. Philadelphia: Lippincott Williams 1999. p. 213-23.
17. Scelo G, Boffetta P, Hemminki K, et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 2006;118:189-96.
18. Brennan P, Scelo G, Hemminki K, et al. Second primary cancers among 109,000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005;93:159-66.
19. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Lyon: IARC; 2002.
20. Muir CS, Percy C. Classification and coding for neoplasms. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. Lyon: IARC; 1991. p. 64-81.
21. Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 1998;34:2167-75.
22. Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:4336-41.
23. Begg CB, Zhang ZF, Sun M, Herr HW, Schantz SP. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol 1995;142:653-65.
24. Slaughter DP, Southwick HW, Smejakl W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
25. Morita M, Kuwano H, Ohno S, et al. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer 1994;58:207-10.
26. Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004;96:99-106.
27. IARC Working Group. Tobacco smoke and involuntary smoking. 2004. p. 1-1438.
28. Ahsan H, Neugut AI, Gammon MD. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomarkers Prev 1997;6:779-82.
29. Evans HS, Lewis CM, Robinson D, et al. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 2001;84:435-40.
30. Kleinerman RA, Boice JD, Jr., Storm HH, et al. Second primary cancer after treatment for cervical cancer. An International Cancer Registries Study. Cancer 1995;76:442-52.
31. Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005;97:1354-65.
32. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
33. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85:1932-7.
34. Allan JM, Travis LB. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 2005;5:943-55.